Morningstar will cease full analyst coverage of Calvert Emerging Markets Equity on or about Sept. 29, 2023, so our analysts can spend more time researching other strategies. In the future, this strategy will receive an algorithmically assigned Morningstar Medalist Rating. Users should form their own views on this strategy or obtain financial advice.
Morningstar’s Analysis CVMAX
Will CVMAX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.